ALPS Medical Breakthroughs ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.50
資產淨值: 51.95
成立日期: 30/12/2014
 
分析
市值分佈:
41.79%
大市值
46.29%
中市值
10.74%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 86  
0%
 
100%
     10大 (30.47%)
代號 名稱 佔比% 持有日期
KALVKalVista Pharmaceuticals0.5327/02/2026
KURAKura Oncology0.4927/02/2026
RIGLRigel Pharmaceuticals Inc0.4127/02/2026
ANROAlto Neuroscience0.3927/02/2026
DSGNDesign Therapeutics0.3827/02/2026
VNDAVanda Pharmaceuticals0.3427/02/2026
FLGTFulgent Genetics0.3127/02/2026
RGNXREGENXBIO0.3027/02/2026
ALTAltimmune0.2927/02/2026
TECXTectonic Therapeutic Inc.0.2827/02/2026
ZURAZura Bio Limited0.2827/02/2026
UPBUpstream Bio Inc0.2727/02/2026
AVXLAnavex Life Sciences Corp0.2627/02/2026
FBRXForte Biosciences Inc0.2427/02/2026
AVIRAtea Pharmaceuticals0.2427/02/2026
NGNENeurogene0.2327/02/2026
AKBAAkebia Therapeutics0.2227/02/2026
TARAProtara Therapeutics0.2127/02/2026
DCTHDelcath Systems0.2027/02/2026
ACRSAclaris Therapeutics0.2027/02/2026
  1    2    3   4    5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.